{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:12Z","timestamp":1786988172919,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejso.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T22:50:56Z","timestamp":1620687056000},"page":"2602-2608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["What is the best front-line approach in patients with desmoid fibromatosis? \u2013 A retrospective analysis from a reference center"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-1626","authenticated-orcid":false,"given":"Pawe\u0142","family":"Sobczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela M.","family":"Agnieszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Grycuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-3810","authenticated-orcid":false,"given":"Anna M.","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"\u015awitaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kose\u0142a-Paterczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Morysi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Zdzienicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-5429","authenticated-orcid":false,"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejso.2021.05.002_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071851","article-title":"Desmoid-type fibromatosis","volume":"12","author":"Garcia-Ortega","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2021.05.002_bib2","series-title":"Soft tissue and bone tumours WHO classification of tumours","author":"Fletcher","year":"2013"},{"issue":"4","key":"10.1016\/j.ejso.2021.05.002_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/CCO.0000000000000374","article-title":"Adult desmoid tumors: biology, management and ongoing trials","volume":"29","author":"Penel","year":"2017","journal-title":"Curr Opin Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2021.05.002_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/gcc.22272","article-title":"Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis","volume":"54","author":"Crago","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2021.05.002_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/jso.24699","article-title":"Comparison of sporadic and FAP-associated desmoid-type fibromatoses","volume":"116","author":"Koskenvuo","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2021.05.002_bib6","first-page":"25","article-title":"Evaluation of estrogen receptor alpha, estrogen receptor beta, progesterone receptor, and cKIT expression in desmoids tumors and their role in determining treatment options","volume":"4","author":"Santos","year":"2010","journal-title":"Biosci Trends"},{"issue":"4","key":"10.1016\/j.ejso.2021.05.002_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejso.2007.06.006","article-title":"Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients","volume":"34","author":"Bonvalot","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2021.05.002_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/SLA.0000000000000224","article-title":"Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk","volume":"259","author":"Fiore","year":"2014","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejso.2021.05.002_bib9","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1245\/s10434-009-0586-2","article-title":"Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment","volume":"16","author":"Fiore","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.002_bib10","first-page":"1","article-title":"Four different treatment strategies in aggressive fibromatosis: a systematic review","volume":"12","author":"Seinen","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ejso.2021.05.002_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients","volume":"127","year":"2020","journal-title":"Eur J Canc"},{"issue":"24","key":"10.1016\/j.ejso.2021.05.002_bib12","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1002\/cncr.33233","article-title":"Desmoid tumors: to treat or not to treat, that is the question","volume":"126","author":"Kasper","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2021.05.002_bib13","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ejso.2020.08.009","article-title":"Event-free survival in Desmoid-Type fibromatosis (DTF): a pre-post comparison of upfront surgery versus wait-and-see approach","volume":"47","author":"Ruspi","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.002_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2017.06.017","article-title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group","volume":"83","author":"Penel","year":"2017","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2021.05.002_bib15","doi-asserted-by":"crossref","first-page":"w20107","DOI":"10.4414\/smw.2019.20107","article-title":"Extra-abdominal desmoid tumours - further evidence for the watchful waiting policy","volume":"149","author":"Krieg","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"13","key":"10.1016\/j.ejso.2021.05.002_bib16","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1245\/s10434-019-07826-6","article-title":"Outcome of primary desmoid tumors at all anatomic locations initially managed with active surveillance","volume":"26","author":"van Houdt","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2021.05.002_bib17","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1200\/JCO.2009.25.5950","article-title":"Successful treatment with meloxicam, a cyclooxygenase-2 inhibitor, of patients with extra-abdominal desmoid tumors: a pilot study","volume":"28","author":"Nishida","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.05.002_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4055\/cios.2018.10.2.225","article-title":"Role of nonsteroidal anti-inflammatory drug in treatment of extra-abdominal desmoid tumors","volume":"10","author":"Cho","year":"2018","journal-title":"Clin Orthop Surg"},{"issue":"4","key":"10.1016\/j.ejso.2021.05.002_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.soc.2016.05.010","article-title":"Desmoid-type fibromatosis: evolving treatment standards","volume":"25","author":"Fiore","year":"2016","journal-title":"Surg Oncol Clin"},{"issue":"Supplement_4","key":"10.1016\/j.ejso.2021.05.002_bib20","doi-asserted-by":"crossref","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali","year":"2018","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2021.05.002_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/SLA.0b013e31828c8a30","article-title":"A\u00a0prognostic nomogram for prediction of recurrence in desmoid fibromatosis","volume":"258","author":"Crago","year":"2013","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2021.05.002_bib22","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2353\/ajpath.2008.080475","article-title":"Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors","volume":"173","author":"Lazar","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2021.05.002_bib23","article-title":"The prognostic role of beta-catenin mutations in desmoid-type fibromatosis undergoing resection only: a meta-analysis of individual patient data","author":"Timbergen","year":"2019","journal-title":"Ann Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321004789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798321004789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:39:21Z","timestamp":1760060361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798321004789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0748798321004789"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.05.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the best front-line approach in patients with desmoid fibromatosis? \u2013 A retrospective analysis from a reference center","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}